Clinical Trials Logo

Clinical Trial Summary

This study will explore neurocognitive performance in pediatric brain tumor patients receiving proton beam radiation therapy (PBRT). The investigators goal is to gather baseline neurocognitive testing prior to the completion of the first week of radiation therapy along with follow-up testing 6-12 months after the completion of radiation and serial annual testing thereafter. With these data the investigators plan to evaluate the effects of PBRT on neurocognitive performance as it relates to patients' age at diagnosis, tumor location, and radiation dose. Modeling studies have demonstrated that PBRT could improve neurocognitive outcomes, but there is a paucity of prospectively-collected patient data. The investigators are uniquely positioned to address this important question given the busy pediatric central nervous system (CNS) tumor service, the delivery of proton therapy at the S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital, and the multi-disciplinary research team with extensive experience into the late effects of therapy as it relates to neurocognition.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02559752
Study type Observational
Source Washington University School of Medicine
Contact Stephanie Perkins, M.D.
Phone 314-747-4405
Email sperkins@wustl.edu
Status Recruiting
Phase
Start date October 13, 2015
Completion date April 30, 2030

See also
  Status Clinical Trial Phase
Completed NCT04014491 - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome N/A
Terminated NCT01006109 - Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT01531920 - A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel Phase 1
Completed NCT02652260 - Effects of Switching From ATRIPLAâ„¢ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Phase 2
Recruiting NCT01541800 - Circulating microRNAs as Disease Markers in Pediatric Cancers N/A
Completed NCT02343718 - Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Phase 1
Completed NCT03430427 - Brain Networks and Mobility Function: B-NET
Completed NCT03830762 - Xanamemâ„¢ in Healthy Elderly Subjects Phase 1
Completed NCT01527006 - Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs Phase 2
Completed NCT01517087 - Studying Motor Neuron Tests
Recruiting NCT05627986 - Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Completed NCT01432288 - Touch and Attention MRI Study N/A
Completed NCT00067067 - Investigating Endothelial Precursor Cells (EPCs) N/A
Completed NCT03268239 - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions N/A
Recruiting NCT04846764 - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) N/A